Sebi Confirms Restrictions on Par Drugs’ Proposed Slump Sale
Regulatory Action Pending Investigation
New Delhi, March 26 – The Securities and Exchange Board of India (Sebi) has confirmed its previous directions against Par Drugs and Chemicals Ltd (PDCL) regarding a proposed slump sale of its...
business transfer
financial transactions
india
investigation
par drugs and chemicals ltd
pdcl
phal-jig fine chemicals pvt ltd
pjfcpl
regulatory compliance
sebi
securities and exchange board of india
shareholder communication
slumpsale
vadodara
valuation
PNGS Reva Diamond Jewellery Shares List at Discount, Debut Amid Market Selloff
PNGS Reva Diamond Jewellery IPO Listing Details
Shares of PNGS Reva Diamond Jewellery Ltd made a subdued debut on the stock exchanges on March 4, listing at a discount of nearly 4 percent to the issue price of Rs 386...
PNGS Reva Diamond Jewellery Shares List at Discount on BSE and NSE After ₹380 Crore IPO
PNGS Reva Diamond Jewellery made a muted debut on the stock exchanges on Wednesday, March 4, as the stock listed below its issue price on both the BSE and NSE.PNGS Reva Diamond Jewellery Listing Price on...
PNGS Reva Diamond Jewellery IPO Subscribed 1.23 Times on Final Day; Retail and NII Segments Lead Demand
The initial public offering of PNGS Reva Diamond Jewellery Ltd was subscribed 1.23 times on Thursday, the final day of bidding, reflecting moderate investor participation across categories...
amit modak
corporate finance
diamond jewellery
equity shares
india
initial public offer
ipo
new stores
nse
p n gadgil & sons ltd
pngs reva diamond jewellery
private equity
retail expansion
retail jewellery
slumpsale
PNGS Reva Diamond Jewellery IPO Subscription Status
The initial public offering of PNGS Reva Diamond Jewellery Ltd witnessed steady investor interest on the second day of bidding on Wednesday, with the issue subscribed 83 per cent overall.According to NSE data, the IPO received bids for...